1 in 9 women in Belgium will develop breast cancer. The treatment is often accompanied by the injection of a radioactive liquid and blue dye that can turn the breast blue for years. To avoid this side effect, Ghent University researcher Loren Deblock is working on a new contrast agent made of... nanocrystals.
Researchers around the world are looking for innovative ways to detect and treat breast cancer. So are experimental oncologist An Hendrix and medical oncologist Hannelore Denys, two top researchers from Ghent.
Cancer researcher Celine Everaert is currently developing an important test that should help to improve treatment for cancer patients. This is possible because of a scholarship, funded by donations and bequests.
Few people have heard of it: peritoneal cancer. However, the disease, especially as a metastasis of another cancer, affects many patients. Unfortunately, it is often too late once the diagnosis is made: existing treatments achieve very little. Groundbreaking research by Professor Wim Ceelen is now resulting in new and promising treatments. And all thanks to the inheritance of a former patient.
Kinderoncoloog Bram De Wilde staat met zijn onderzoek mogelijk voor een doorbraak. Ondanks de farma-industrie: "De groep patiënten is te klein voor de farmabedrijven, dus zij investeren er niet in." En dus moest de financiering van elders komen.
If you get cancer, it often means intensive medical treatment right away. But cancer patients are more than just their illness, and treatments are more than just medical help. Professor Tessa Kerre emphasizes the importance of kinder care. The Ghent University reading project is a good example of this.
At Ghent University, many researchers work hard each day to improve cancer treatment and thus extend our life expectation. However, research takes time. Tremendous time. And money. Postdoctoral research Dr. Heleen Dewitte knows all about it.
